Mr. Hector Bremner reports

AVRICORE GRANTS OPTIONS

Avricore Health Inc.'s board of directors has approved the granting of stock options exercisable for a total of 3,361,000 common shares to its directors, officers, employees and consultants at an exercise price of 29 cents per common share.

All options were granted pursuant to the company's stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.

The options shall vest quarterly commencing on the date of grant. The options expire five years from the date of the grant, subject to the optionees continuing to act as directors, officers, employees or consultants of the company.

About Avricore Health Inc.

Avricore is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. Through its flagship offering HealthTab, a wholly owned subsidiary, the company's mission is to make actionable health information more accessible to everyone by creating the world's largest network of rapid testing devices in community pharmacies.

We seek Safe Harbor.